Ion transporters in brain tumors

Current Medicinal Chemistry

Volumn 22, Issue 10, 2015, Pages 1171-1181

  Cong, Damin ^a,b   Zhu, Wen ^b   S Kuo, John ^c   Hu, Shaoshan ^a   Sun, Dandan ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bumetanide; Cancer progression; Cariporide; NHE 1; NKCC 1; Targeted therapy

Indexed keywords

CALCIUM ION; CARRIER PROTEINS AND BINDING PROTEINS; CELL MEMBRANE PROTEIN; POTASSIUM ION; SODIUM HYDROGEN EXCHANGER ISOFORM 1; SODIUM ION; SODIUM POTASSIUM CHLORIDE COTRANSPORTER ISOFORM 1; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; SLC12A2 PROTEIN, HUMAN; SLC9A1 PROTEIN, HUMAN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; SODIUM PROTON EXCHANGE PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL VOLUME; DOWN REGULATION; GLIOBLASTOMA; HUMAN; INTRACELLULAR KILLING; ION TRANSPORT; LIVER CELL CARCINOMA; LUNG CANCER; SIGNAL TRANSDUCTION; BRAIN TUMOR; METABOLISM;

BRAIN NEOPLASMS; CATION TRANSPORT PROTEINS; HUMANS; ION TRANSPORT; SODIUM-HYDROGEN ANTIPORTER; SOLUTE CARRIER FAMILY 12, MEMBER 2;

EID: 84931271385     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150114151946     Document Type: Article

References (128)

1. Stupp, R.; Pavlidis, N.; Jelic, S. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma. Ann. Oncol., 2005, 16 Suppl 1, i64-65.
2. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: The next generation. Cell, 2011, 144(5), 646-674.
3. Arcangeli, A.; Crociani, O.; Lastraioli, E.; Masi, A.; Pillozzi, S.; Becchetti, A. Targeting ion channels in cancer: A novel frontier in antineoplastic therapy. Curr. Med. Chem., 2009, 16(1), 66-93.
4. Fiske, J. L.; Fomin, V. P.; Brown, M. L.; Duncan, R. L.; Sikes, R. A. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev., 2006, 25(3), 493-500.
5. Fraser, S. P.; Pardo, L. A. Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep., 2008, 9(6), 512-515.
6. Kunzelmann, K. Ion channels and cancer. J Membr Biol, 2005, 205(3), 159-173.
7. Prevarskaya, N.; Skryma, R.; Shuba, Y. Ion channels and the hallmarks of cancer. Trends Mol. Med., 2010, 16(3), 107-121.
8. Ouadid-Ahidouch, H.; Roudbaraki, M.; Delcourt, P.; Ahidouch, A.; Joury, N.; Prevarskaya, N. Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: Association with cell cycle progression. Am. J. Physiol. Cell Physiol., 2004, 287(1), C125-134.
9. Hara, Y.; Wakamori, M.; Ishii, M.; Maeno, E.; Nishida, M.; Yoshida, T.; Yamada, H.; Shimizu, S.; Mori, E.; Kudoh, J.; Shimizu, N.; Kurose, H.; Okada, Y.; Imoto, K.; Mori, Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell, 2002, 9(1), 163-173.
10. Brackenbury, W. J.; Chioni, A. M.; Diss, J. K.; Djamgoz, M. B. The neonatal splice variant of Nav1. 5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat., 2007, 101(2), 149-160.
11. Diss, J. K.; Stewart, D.; Pani, F.; Foster, C. S.; Walker, M. M.; Patel, A.; Djamgoz, M. B. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis., 2005, 8(3), 266-273.
12. Liu, M.; Inoue, K.; Leng, T.; Guo, S.; Xiong, Z. G. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways. Cell Signal., 2014, 26(12), 2773-2781.
13. Gagnon, K. B. High-grade glioma motility reduced by genetic knockdown of KCC3. Cell Physiol. Biochem., 2012, 30(2), 466-476.
14. Chen, D.; Song, M.; Mohamad, O.; Yu, S. P. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer, 2014, 14(1), 716.
15. Russell, J. M. Sodium-potassium-chloride cotransport. Physiol. Rev., 2000, 80(1), 211-276.
16. Haas, M.; Forbush, B., 3rd. The Na-K-Cl cotransporter of secretory epithelia. Annu. Rev. Physiol., 2000, 62, 515-534.
17. Payne, J. A.; Xu, J. C.; Haas, M.; Lytle, C. Y.; Ward, D.; Forbush, B., 3rd. Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon. J. Biol. Chem., 1995, 270(30), 17977-17985.
18. Xu, J. C.; Lytle, C.; Zhu, T. T.; Payne, J. A.; Benz, E., Jr.; Forbush, B., 3rd. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter. Proc. Natl. Acad. Sci. U S A, 1994, 91(6), 2201-2205.
19. Payne, J. A.; Forbush, B., 3rd. Alternatively spliced isoforms of the putative renal Na-K-Cl cotransporter are differentially distributed within the rabbit kidney. Proc. Natl. Acad. Sci. U S A, 1994, 91(10), 4544-4548.
20. Chen, H.; Sun, D. The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol. Res., 2005, 27(3), 280-286.
21. Greger, R. The membrane transporters regulating epithelial NaCl secretion. Pflugers. Arch., 1996, 432(4), 579-588.
22. Darman, R. B.; Forbush, B. A regulatory locus of phosphorylation in the N terminus of the Na-K-Cl cotransporter, NKCC1. J. Biol. Chem., 2002, 277(40), 37542-37550.
23. Flemmer, A. W.; Gimenez, I.; Dowd, B. F.; Darman, R. B.; Forbush, B. Activation of the Na-K-Cl cotransporter NKCC1 detected with a phospho-specific antibody. J. Biol. Chem., 2002, 277(40), 37551-37558.
24. Foroutan, S.; Brillault, J.; Forbush, B.; O'Donnell, M. E. Moderateto-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Clcotransporter. Am. J. Physiol. Cell Physiol., 2005, 289(6), C1492-1501.
25. Jayakumar, A. R.; Norenberg, M. D. The Na-K-Cl Co-transporter in astrocyte swelling. Metab. Brain Dis., 2010, 25(1), 31-38.
26. Lytle, C.; Forbush, B., 3rd. The Na-K-Cl cotransport protein of shark rectal gland. II. Regulation by direct phosphorylation. J. Biol. Chem., 1992, 267(35), 25438-25443.
27. McCormick, J. A.; Ellison, D. H. The WNKs: Atypical protein kinases with pleiotropic actions. Physiol. Rev., 2011, 91(1), 177-219.
28. Richardson, C.; Alessi, D. R. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J. Cell Sci., 2008, 121(Pt 20), 3293-3304.
29. Richardson, C.; Rafiqi, F. H.; Karlsson, H. K.; Moleleki, N.; Vandewalle, A.; Campbell, D. G.; Morrice, N. A.; Alessi, D. R. Activation of the thiazide-sensitive Na+-Cl-cotransporter by the WNK-regulated kinases SPAK and OSR1. J. Cell Sci., 2008, 121(Pt 5), 675-684.
30. Thastrup, J. O.; Rafiqi, F. H.; Vitari, A. C.; Pozo-Guisado, E.; Deak, M.; Mehellou, Y.; Alessi, D. R. SPAK/OSR1 regulate NKCC1 and WNK activity: Analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation. Biochem. J., 2012, 441(1), 325-337.
31. Delpire, E.; Rauchman, M. I.; Beier, D. R.; Hebert, S. C.; Gullans, S. R. Molecular cloning and chromosome localization of a putative basolateral Na(+)-K(+)-2Cl-cotransporter from mouse inner medullary collecting duct (mIMCD-3) cells. J. Biol. Chem., 1994, 269(41), 25677-25683.
32. Di Ciano-Oliveira, C.; Sirokmany, G.; Szaszi, K.; Arthur, W. T.; Masszi, A.; Peterson, M.; Rotstein, O. D.; Kapus, A. Hyperosmotic stress activates Rho: differential involvement in Rho kinasedependent MLC phosphorylation and NKCC activation. Am. J. Physiol. Cell Physiol., 2003, 285(3), C555-C566.
33. Darman, R. B.; Flemmer, A.; Forbush, B. Modulation of ion transport by direct targeting of protein phosphatase type 1 to the Na-K-Cl cotransporter. J. Biol. Chem., 2001, 276(37), 34359-34362.
34. Jayakumar, A. R.; Liu, M.; Moriyama, M.; Ramakrishnan, R.; Forbush, B., 3rd; Reddy, P. V.; Norenberg, M. D. Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J. Biol. Chem., 2008, 283(49), 33874-33882.
35. Elliott, S. J.; Schilling, W. P. Oxidant stress alters Na+ pump and Na(+)-K(+)-Cl-cotransporter activities in vascular endothelial cells. Am. J. Physiol., 1992, 263(1 Pt 2), H96-102.
36. Ortiz, P. A.; Hong, N. J.; Garvin, J. L. NO decreases thick ascending limb chloride absorption by reducing Na(+)-K(+)-2Cl(-) cotransporter activity. Am. J. Physiol. Renal. Physiol., 2001, 281(5), F819-825.
37. Plato, C. F.; Stoos, B. A.; Wang, D.; Garvin, J. L. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am. J. Physiol., 1999, 276(1 Pt 2), F159-163.
38. He, H.; Podymow, T.; Zimpelmann, J.; Burns, K. D. NO inhibits Na+-K+-2Cl-cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1). Am. J. Physiol. Renal Physiol., 2003, 284(6), F1235-1244.
39. Habela, C. W.; Sontheimer, H. Cytoplasmic volume condensation is an integral part of mitosis. Cell Cycle, 2007, 6(13), 1613-1620.
40. Bussolati, O.; Uggeri, J.; Belletti, S.; Dall'Asta, V.; Gazzola, G. C. The stimulation of Na, K, Cl cotransport and of system A for neutral amino acid transport is a mechanism for cell volume increase during the cell cycle. FASEB J., 1996, 10(8), 920-926.
41. Jiang, G.; Klein, J. D.; O'Neill, W. C. Growth factors stimulate the Na-K-2Cl cotransporter NKCC1 through a novel Cl(-)-dependent mechanism. Am. J. Physiol. Cell Physiol., 2001, 281(6), C1948-1953.
42. Panet, R.; Marcus, M.; Atlan, H. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts. J. Cell Physiol., 2000, 182(1), 109-118.
43. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: The next generation. Cell, 2012, 144(5), 646-674.
44. Bortner, C. D.; Cidlowski, J. A. Apoptotic volume decrease and the incredible shrinking cell. Cell Death Differ., 2002, 9(12), 1307-1310.
45. Maeno, E.; Ishizaki, Y.; Kanaseki, T.; Hazama, A.; Okada, Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. U S A, 2000, 97(17), 9487-9492.
46. Chimote, A. A.; Adragna, N. C.; Lauf, P. K. Ion transport in a human lens epithelial cell line exposed to hyposmotic and apoptotic stress. J. Cell Physiol., 2010, 223(1), 110-122.
47. Maeno, E.; Takahashi, N.; Okada, Y. Dysfunction of regulatory volume increase is a key component of apoptosis. FEBS Lett., 2006, 580(27), 6513-6517.
48. Algharabil, J.; Kintner, D. B.; Wang, Q.; Begum, G.; Clark, P. A.; Yang, S. S.; Lin, S. H.; Kahle, K. T.; Kuo, J. S.; Sun, D. Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells. Cell Physiol. Biochem., 2012, 30(1), 33-48.
49. Stupp, R.; Mason, W. P.; van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352(10), 987-996.
50. Zhu, W.; Wang, Q.; Clark, P. A.; Yang, S.-S.; Lin, S.-H.; Kahle, K. T.; Kuo, J. S.; Sun, D. Temozolomid activates upstream kinases of Na+-K+-Cl-cotransporter isoform 1 in glioblastoma cancer cells. Neuro-Oncology, 2012, 14(suppl 6), vi7-vi20.
51. Zhu, W.; Begum, G.; Pointer, K.; Clark, P. A.; Yang, S. S.; Lin, S. H.; Kahle, K. T.; Kuo, J. S.; Sun, D. WNK1-OSR1 kinasemediated phospho-activation of Na+-K+-2Cl-cotransporter facilitates glioma migration. Mol. Cancer, 2014, 13, 31.
52. Jakab, M.; Ritter, M. Cell volume regulatory ion transport in the regulation of cell migration. Contrib. Nephrol., 2006, 152, 161-180.
53. Cuddapah, V. A.; Sontheimer, H. Ion channels and transporters corrected in cancer. 2. Ion channels and the control of cancer cell migration. Am. J. Physiol. Cell Physiol., 2011, 301(3) C541-549
54. Mejia-Gervacio, S.; Murray, K.; Lledo, P. M. NKCC1 controls GABAergic signaling and neuroblast migration in the postnatal forebrain. Neural Dev., 2011, 6, 4.
55. Johnson, M. D.; O'Connell, M. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Hum. Pathol., 2013.
56. Garzon-Muvdi, T.; Schiapparelli, P.; ap Rhys, C.; Guerrero-Cazares, H.; Smith, C.; Kim, D. H.; Kone, L.; Farber, H.; Lee, D. Y.; An, S. S.; Levchenko, A.; Quinones-Hinojosa, A. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS Biol., 2012, 10(5), e1001320.
57. Haas, B. R.; Cuddapah, V. A.; Watkins, S.; Rohn, K. J.; Dy, T. E.; Sontheimer, H. With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume. Am. J. Physiol. Cell Physiol., 2011, 301(5), C1150-1160.
58. Haas, B. R.; Sontheimer, H. Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. Cancer Res., 2010, 70(13), 5597-5606.
59. Denker, S. P.; Barber, D. L. Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J. Cell Biol., 2002, 159(6), 1087-1096.
60. Loscher, W.; Puskarjov, M.; Kaila, K. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology, 2013, 69, 62-74.
61. Kahle, K. T.; Simard, J. M.; Staley, K. J.; Nahed, B. V.; Jones, P. S.; Sun, D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda), 2009, 24, 257-265.
62. Marty, A.; Llano, I. Excitatory effects of GABA in established brain networks. Trends Neurosci., 2005, 28(6), 284-289.
63. Woodruff, A. R.; Anderson, S. A.; Yuste, R. The enigmatic function of chandelier cells. Front Neurosci., 2010, 4, 201.
64. Khirug, S.; Yamada, J.; Afzalov, R.; Voipio, J.; Khiroug, L.; Kaila, K. GABAergic depolarization of the axon initial segment in cortical principal neurons is caused by the Na-K-2Cl cotransporter NKCC1. J. Neurosci., 2008, 28(18), 4635-4639.
65. Kahle, K. T.; Staley, K. Altered neuronal chloride homeostasis and excitatory GABAergic signaling in human temporal lobe epilepsy. Epilepsy Curr., 2008, 8(2), 51-53.
66. Brandt, C.; Nozadze, M.; Heuchert, N.; Rattka, M.; Loscher, W. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J Neurosci., 2010, 30(25), 8602-8612.
67. Li, Y.; Cleary, R.; Kellogg, M.; Soul, J. S.; Berry, G. T.; Jensen, F. E. Sensitive isotope dilution liquid chromatography/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2011, 879(13-14), 998-1002.
68. Malo, M. E.; Fliegel, L. Physiological role and regulation of the Na+/H+ exchanger. Can. J Physiol. Pharmacol., 2006, 84(11), 1081-1095.
69. Fliegel, L. The Na+/H+ exchanger isoform 1. Int. J. Biochem. Cell Biol., 2005, 37(1), 33-37.
70. Fliegel, L.; Sardet, C.; Pouyssegur, J.; Barr, A. Identification of the protein and cDNA of the cardiac Na+/H+ exchanger. FEBS Lett., 1991, 279(1), 25-29.
71. Luo, J.; Sun, D. Physiology and pathophysiology of Na(+)/H(+) exchange isoform 1 in the central nervous system. Curr. Neurovasc. Res., 2007, 4(3), 205-215.
72. Wakabayashi, S.; Sardet, C.; Fafournoux, P.; Counillon, L.; Meloche, S.; Pages, G.; Pouyssegur, J. Structure function of the growth factor-activatable Na+/H+ exchanger (NHE1). Rev. Physiol. Biochem. Pharmacol., 1992, 119, 157-186.
73. Orlowski, J.; Kandasamy, R. A.; Shull, G. E. Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins. J. Biol. Chem., 1992, 267(13), 9331-9339.
74. Noel, J.; Roux, D.; Pouyssegur, J. Differential localization of Na+/H+ exchanger isoforms (NHE1 and NHE3) in polarized epithelial cell lines. J. Cell Sci., 1996, 109 ( Pt 5), 929-939.
75. Attaphitaya, S.; Park, K.; Melvin, J. E. Molecular cloning and functional expression of a rat Na+/H+ exchanger (NHE5) highly expressed in brain. J. Biol. Chem., 1999, 274(7), 4383-4388.
76. Nakamura, N.; Tanaka, S.; Teko, Y.; Mitsui, K.; Kanazawa, H. Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J. Biol. Chem., 2005, 280(2), 1561-1572.
77. Reshkin, S. J.; Cardone, R. A.; Harguindey, S. Na+-H+ exchanger, pH regulation and cancer. Recent Pat. Anticancer Drug Discov., 2012, 8(1), 85-99.
78. Sardet, C.; Franchi, A.; Pouyssegur, J. Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter. Cell, 1989, 56(2), 271-280.
79. Khaled, A. R.; Moor, A. N.; Li, A.; Kim, K.; Ferris, D. K.; Muegge, K.; Fisher, R. J.; Fliegel, L.; Durum, S. K. Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol. Cell Biol., 2001, 21(22), 7545-7557.
80. Slepkov, E. R.; Rainey, J. K.; Sykes, B. D.; Fliegel, L. Structural and functional analysis of the Na+/H+ exchanger. Biochem. J, 2007, 401(3), 623-633.
81. Loo, S. Y.; Chang, M. K.; Chua, C. S.; Kumar, A. P.; Pervaiz, S.; Clement, M. V. NHE-1: A promising target for novel anti-cancer therapeutics. Curr. Pharm. Des., 2012, 18(10), 1372-1382.
82. Wakabayashi, S.; Hisamitsu, T.; Pang, T.; Shigekawa, M. Kinetic dissection of two distinct proton binding sites in Na+/H+ exchangers by measurement of reverse mode reaction. J. Biol. Chem., 2003, 278(44), 43580-43585.
83. Putney, L. K.; Denker, S. P.; Barber, D. L. The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol., 2002, 42, 527-552
84. Lin, X.; Barber, D. L. A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. Proc. Natl. Acad. Sci. U S A, 1996, 93(22), 12631-12636.
85. Sardet, C.; Fafournoux, P.; Pouyssegur, J. Alpha-thrombin, epidermal growth factor, and okadaic acid activate the Na+/H+ exchanger, NHE-1, by phosphorylating a set of common sites. J. Biol. Chem., 1991, 266(29), 19166-19171.
86. Cuello, F.; Snabaitis, A. K.; Cohen, M. S.; Taunton, J.; Avkiran, M. Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation. Mol. Pharmacol., 2007, 71(3), 799-806.
87. Malo, M. E.; Li, L.; Fliegel, L. Mitogen-activated protein kinasedependent activation of the Na+/H+ exchanger is mediated through phosphorylation of amino acids Ser770 and Ser771. J. Biol. Chem., 2007, 282(9), 6292-6299.
88. Takahashi, E.; Abe, J.; Gallis, B.; Aebersold, R.; Spring, D. J.; Krebs, E. G.; Berk, B. C. p90(RSK) is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory phosphorylation of serine 703 of Na+/H+ exchanger isoform-1. J. Biol. Chem., 1999, 274(29), 20206-20214.
89. Lehoux, S.; Abe, J.; Florian, J. A.; Berk, B. C. 14-3-3 Binding to Na+/H+ exchanger isoform-1 is associated with serum-dependent activation of Na+/H+ exchange. J. Biol. Chem., 2001, 276(19), 15794-15800.
90. Misik, A. J.; Perreault, K.; Holmes, C. F.; Fliegel, L. Protein phosphatase regulation of Na+/H+ exchanger isoform I. Biochemistry, 2005, 44(15), 5842-5852.
91. Harguindey, S.; Orive, G.; Luis Pedraz, J.; Paradiso, A.; Reshkin, S. J. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim. Biophys. Acta., 2005, 1756(1), 1-24.
92. Glunde, K.; Dussmann, H.; Juretschke, H. P.; Leibfritz, D. Na(+)/H(+) exchange subtype 1 inhibition during extracellular acidification and hypoxia in glioma cells. J. Neurochem., 2002, 80(1), 36-44.
93. Reshkin, S. J.; Bellizzi, A.; Caldeira, S.; Albarani, V.; Malanchi, I.; Poignee, M.; Alunni-Fabbroni, M.; Casavola, V.; Tommasino, M. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J., 2000, 14(14), 2185-2197.
94. Stock, C.; Schwab, A. Protons make tumor cells move like clockwork. Pflugers. Arch., 2009, 458(5), 981-992.
95. Gillies, R. J.; Raghunand, N.; Karczmar, G. S.; Bhujwalla, Z. M. MRI of the tumor microenvironment. J. Magn. Reson. Imaging, 2002, 16(4), 430-450.
96. Matsuyama, S.; Llopis, J.; Deveraux, Q. L.; Tsien, R. Y.; Reed, J. C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell Biol., 2000, 2(6), 318-325.
97. Lang, F.; Madlung, J.; Bock, J.; Lukewille, U.; Kaltenbach, S.; Lang, K. S.; Belka, C.; Wagner, C. A.; Lang, H. J.; Gulbins, E.; Lepple-Wienhues, A. Inhibition of Jurkat-T-lymphocyte Na+/H+-exchanger by CD95(Fas/Apo-1)-receptor stimulation. Pflugers. Arch., 2000, 440(6), 902-907.
98. Wu, K. L.; Khan, S.; Lakhe-Reddy, S.; Wang, L.; Jarad, G.; Miller, R. T.; Konieczkowski, M.; Brown, A. M.; Sedor, J. R.; Schelling, J. R. Renal tubular epithelial cell apoptosis is associated with caspase cleavage of the NHE1 Na+/H+ exchanger. Am. J. Physiol. Renal Physiol., 2003, 284(4), F829-839.
99. Cho, Y. L.; Lee, K. S.; Lee, S. J.; Namkoong, S.; Kim, Y. M.; Lee, H.; Ha, K. S.; Han, J. A.; Kwon, Y. G. Amiloride potentiates TRAILinduced tumor cell apoptosis by intracellular acidificationdependent Akt inactivation. Biochem. Biophys. Res. Commun., 2005, 326(4), 752-758.
100. Nylandsted, J.; Jaattela, M.; Hoffmann, E. K.; Pedersen, S. F. Heat shock protein 70 inhibits shrinkage-induced programmed cell death via mechanisms independent of effects on cell volume-regulatory membrane transport proteins. Pflugers. Arch., 2004, 449(2), 175-185.
101. Pedersen, S. F. The Na+/H+ exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death. Pflugers. Arch., 2006, 452(3), 249-259.
102. Kondo, T.; Takeuchi, K.; Doi, Y.; Yonemura, S.; Nagata, S.; Tsukita, S. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J. Cell Biol., 1997, 139(3), 749-758.
103. Wu, K. L.; Khan, S.; Lakhe-Reddy, S.; Jarad, G.; Mukherjee, A.; Obejero-Paz, C. A.; Konieczkowski, M.; Sedor, J. R.; Schelling, J. R. The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem., 2004, 279(25), 26280-26286.
104. Yang, X.; Wang, D.; Dong, W.; Song, Z.; Dou, K. Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target. J. Gastroenterol. Hepatol., 2011, 26(2), 364-370.
105. Joyce, J. A.; Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer, 2009, 9(4), 239-252.
106. Gatenby, R. A.; Gawlinski, E. T. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res., 2003, 63(14), 3847-3854.
107. Webb, S. D.; Sherratt, J. A.; Fish, R. G. Modelling tumour acidity and invasion. Novartis. Found Symp., 2001, 240, 169-181; discussion 181-165.
108. Glunde, K.; Guggino, S. E.; Solaiyappan, M.; Pathak, A. P.; Ichikawa, Y.; Bhujwalla, Z. M. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia, 2003, 5(6), 533-545.
109. Bourguignon, L. Y.; Singleton, P. A.; Diedrich, F.; Stern, R.; Gilad, E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem, 2004, 279(26), 26991-27007.
110. Lin, Y.; Chang, G.; Wang, J.; Jin, W.; Wang, L.; Li, H.; Ma, L.; Li, Q.; Pang, T. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. Exp. Cell Res., 2011, 317(14), 2031-2040.
111. Cardone, R. A.; Casavola, V.; Reshkin, S. J. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer, 2005, 5(10), 786-795.
112. Itoh, Y.; Seiki, M. MT1-MMP: A potent modifier of pericellular microenvironment. J. Cell. Physiol., 2006, 206(1), 1-8.
113. Kostidou, E.; Koliakos, G.; Alamdari, D. H.; Paletas, K.; Tsapas, A.; Kaloyianni, M. Enhanced laminin carbonylation by monocytes in diabetes mellitus. Clin. Biochem., 2007, 40(9-10), 671-679.
114. Verfaillie, C. M.; Benis, A.; Iida, J.; McGlave, P. B.; McCarthy, J. B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood, 1994, 84(6), 1802-1811.
115. Stock, C.; Gassner, B.; Hauck, C. R.; Arnold, H.; Mally, S.; Eble, J. A.; Dieterich, P.; Schwab, A. Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange. J. Physiol., 2005, 567(Pt 1), 225-238.
116. McHardy, L. M.; Sinotte, R.; Troussard, A.; Sheldon, C.; Church, J.; Williams, D. E.; Andersen, R. J.; Dedhar, S.; Roberge, M.; Roskelley, C. D. The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Res., 2004, 64(4), 1468-1474.
117. Paradiso, A.; Cardone, R. A.; Bellizzi, A.; Bagorda, A.; Guerra, L.; Tommasino, M.; Casavola, V.; Reshkin, S. J. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res., 2004, 6(6), R616-R628.
118. Reshkin, S. J.; Bellizzi, A.; Albarani, V.; Guerra, L.; Tommasino, M.; Paradiso, A.; Casavola, V. Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J. Biol. Chem., 2000, 275(8), 5361-5369.
119. Thiry, A.; Supuran, C. T.; Masereel, B.; Dogne, J. M. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J. Med. Chem., 2008, 51(11), 3051-3056.
120. Hegde, M.; Roscoe, J.; Cala, P.; Gorin, F. Amiloride kills malignant glioma cells independent of its inhibition of the sodiumhydrogen exchanger. J. Pharmacol. Exp. Ther., 2004, 310(1), 67-74.
121. Paukert, M.; Babini, E.; Pusch, M.; Grunder, S. Identification of the Ca2+ blocking site of acid-sensing ion channel (ASIC) 1: implications for channel gating. J Gen. Physiol., 2004, 124(4), 383-394.
122. Humphreys, R. A.; Haist, J. V.; Chakrabarti, S.; Feng, Q.; Arnold, J. M.; Karmazyn, M. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am. J. Physiol., 1999, 276(2 Pt 2), H749-757.
123. Pederson, S. F.; Varming, C.; Christensen, S. T.; Hoffmann, E. K. Mechanisms of activation of NHE by cell shrinkage and by calyculin A in Ehrlich ascites tumor cells. J Membr. Biol., 2002, 189(1), 67-81.
124. Matthews, H.; Ranson, M.; Kelso, M. J. Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: An orally active anti-cancer drug waiting for its call-of-duty? Int. J. Cancer, 2011, 129(9), 2051-2061.
125. Rogister, F.; Laeckmann, D.; Plasman, P.; Van Eylen, F.; Ghyoot, M.; Maggetto, C.; Liegeois, J.; Geczy, J.; Herchuelz, A.; Delarge, J.; Masereel, B. Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives. Eur. J. Med. Chem., 2001, 36(7-8), 597-614.
126. Harguindey, S.; Arranz, J. L.; Polo Orozco, J. D.; Rauch, C.; Fais, S.; Cardone, R. A.; Reshkin, S. J. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs-an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. J. Transl. Med., 2013, 11, 282.
127. Mentzer, R. M., Jr.; Bartels, C.; Bolli, R.; Boyce, S.; Buckberg, G. D.; Chaitman, B.; Haverich, A.; Knight, J.; Menasche, P.; Myers, M. L.; Nicolau, J.; Simoons, M.; Thulin, L.; Weisel, R. D. Sodiumhydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann. Thorac. Surg., 2008, 85(4), 1261-1270.
128. Avkiran, M.; Cook, A. R.; Cuello, F. Targeting Na+/H+ exchanger regulation for cardiac protection: A RSKy approach? Curr. Opin. Pharmacol., 2008, 8(2), 133-140.